Gibson Assembly enables the rapid assembly of multiple DNA fragments using a one-step, isothermal reaction. Developed by Dr. Daniel Gibson and his colleagues at the J. Craig Venter Institute (JCVI), as part of a program sponsored by Synthetic Genomics, Inc. (SGI), Gibson Assembly has become a mainstay in the laboratories of many synthetic biologists and is now catching on in the wider life science community, due to its ease-of-use, robustness and flexibility. The Gibson Assembly Cloning Kit builds upon this by combining the power of the Gibson Assembly Master Mix, which was first commercialized by NEB in February 2012, with NEB 5-alpha competent E. coli, enabling fragment assembly and cloning in less than two hours.

"As a leader in the discovery and development of cloning tools and technologies, NEB has embraced Gibson Assembly and further developed its protocol for cloning," states Dr. Bill Jack, Director of Research at NEB. "While traditional cloning methods remain important standard practices in the laboratory, this alternative method delivers additional speed, flexibility and ease-of-use."

"SGI is pleased to expand the portfolio of products commercialized with NEB and to further enable scientific progress in the fields of synthetic biology and DNA cloning," states Fernanda Gandara, SVP, at SGI.

The Gibson Assembly Cloning Kit includes protocols for primer design, and has been optimized for the assembly of 1 or more DNA fragments into a linearized vector. Alongside this new kit, NEB has also developed NEBuilder, an online primer design tool, specifically for use in Gibson Assembly.

For more information about the Gibson Assembly Cloning Kit, or to access the primer design tool, visit NEBGibson.com.

About New England BiolabsEstablished in the mid 1970's, New England Biolabs, Inc. is the industry leader in the discovery and production of enzymes for molecular biology applications and now offers the largest selection of recombinant and native enzymes for genomic research. NEB continues to expand its product offerings into areas related to PCR, gene expression, sample preparation for next generation sequencing, cellular analysis, epigenetics and RNA analysis. Additionally, NEB is focused on strengthening alliances that enable new technologies to reach key market sectors. New England Biolabs is a privately held company, headquartered in Ipswich, MA, and has extensive worldwide distribution through a network of exclusive distributors, agents and six subsidiaries located in Canada, China, France, Germany, Japan and the UK. For more information about New England Biolabs visit www.NEBGibson.com

Gibson Assembly is a trademark of Synthetic Genomics, Inc. NEBuilder is a trademark of New England Biolabs, Inc.